Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT03053102 · COMPLETED
Trial details
- NCT number
- NCT03053102
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2018-11-14
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.